Patient Identification

Identifying the Ideal Patient Population for Your Study

To facilitate the identification of the right patient population for each oncology compound, Champions TumorGrafts® are highly characterized, with the following data available to guide model selection and analysis:

  • Gene expression profile
  • Oncogene mutations
  • Growth and response to standard of care agents
  • Clinical annotations from patients

Our platform enables identification of the most promising development path for a compound in terms of:

  • Tumor types
  • Drug combinations
  • Biomarkers
  • Patient subpopulations

And the platform eliminates wasted development time and expense on not-likely-to-respond indications and patient populations.


Explore the TumorGraft Database